The Spectrum of Cardiovascular Prevention: Obesity Paradox, Physical Activity, Sedentary Behaviors and Emerging Therapeutics in Type 2 Diabetes Mellitus

A conversation with Salvatore Carbone, PhD, Assistant Professor at the Department of Kinesiology & Health Sciences, College of Humanities & Sciences at the Virginia Commonwealth University in Richmond, VA. CARDIOMETABOLIC CHRONICLE: An interesting concept that has been proposed is the “obesity paradox,” a view that obesity confers some sort of protection for adverse CV events. […]

The Utility of Genetic Testing in Cardiometabolic Health

Genetic testing is one of the cornerstones of personalized medicine, and while this approach has made significant strides in other therapeutic areas, such as cancer, the utility and applicability of genetic testing in cardiometabolic disease remains a novel area of investigation. However, there are certain high-risk familial cardiometabolic conditions where genetic testing is currently a […]

NASH Clinical Trials: An Outlook On Challenges and Advances

Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS) and defined as the accumulation of fat in the liver in patients who do not consume significant amounts of alcohol.1 NAFLD encompasses a wide spectrum of conditions, from simple fat accumulation (fatty liver) to steatohepatitis (NASH) with or without fibrosis up […]

Pages: 1 2 3 4 5 6